相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。scPNMF: sparse gene encoding of single cells to facilitate gene selection for targeted gene profiling
Dongyuan Song et al.
BIOINFORMATICS (2021)
KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study
Simone Ferrero et al.
HAEMATOLOGICA (2020)
The evolutionary history of 2,658 cancers
Moritz Gerstung et al.
NATURE (2020)
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing
Prasath Pararajalingam et al.
BLOOD (2020)
The ChinaMAP analytics of deep whole genome sequences in 10,588 individuals
Yanan Cao et al.
CELL RESEARCH (2020)
Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes
Ferran Nadeu et al.
BLOOD (2020)
Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis
Holly A. Hill et al.
BLOOD ADVANCES (2020)
Emerging therapies in mantle cell lymphoma
Walter Hanel et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management
Preetesh Jain et al.
AMERICAN JOURNAL OF HEMATOLOGY (2019)
Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
Liang Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies
Steffen Boettcher et al.
SCIENCE (2019)
Dynamic molecular monitoring reveals that SWI-SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma
Rishu Agarwal et al.
NATURE MEDICINE (2019)
Mutant p53 drives clonal hematopoiesis through modulating epigenetic pathway
Sisi Chen et al.
NATURE COMMUNICATIONS (2019)
A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome
Guillem Clot et al.
BLOOD (2018)
Understanding resistance mechanisms to BTK and BCL2 inhibitors in mantle cell lymphoma: implications for design of clinical trials
Rishu Agarwal et al.
LEUKEMIA & LYMPHOMA (2018)
Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes
Bjoern Chapuy et al.
NATURE MEDICINE (2018)
MutationalPatterns: comprehensive genome-wide analysis of mutational processes
Francis Blokzijl et al.
GENOME MEDICINE (2018)
Expression of TP53 is associated with the outcome of MCL independent of MIPI and Ki-67 in trials of the European MCL Network
Sietse M. Aukema et al.
BLOOD (2018)
Autoimmunity checkpoints as therapeutic targets in B cell malignancies
Markus Muschen
NATURE REVIEWS CANCER (2018)
Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening
Julia Joung et al.
NATURE PROTOCOLS (2017)
TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy
Christian W. Eskelund et al.
BLOOD (2017)
Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management
Julie M. Vose
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Zuguang Gu et al.
BIOINFORMATICS (2016)
Decoding the DNA Methylome of Mantle Cell Lymphoma in the Light of the Entire B Cell Lineage
Ana C. Queiros et al.
CANCER CELL (2016)
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations
Chenglin Wu et al.
ONCOTARGET (2016)
CCND1 mutations increase protein stability and promote ibrutinib resistance in mantle cell lymphoma
Atish Mohanty et al.
ONCOTARGET (2016)
High-dose cytarabine does not overcome the adverse prognostic value of CDKN2A and TP53 deletions in mantle cell lymphoma
Marie-Helene Delfau-Larue et al.
BLOOD (2015)
Early B-cell-specific inactivation of ATM synergizes with ectopic CyclinD1 expression to promote pre-germinal center B-cell lymphomas in mice
K. Yamamoto et al.
LEUKEMIA (2015)
Mutations driving CLL and their evolution in progression and relapse
Dan A. Landau et al.
NATURE (2015)
Comprehensive assessment of cancer missense mutation clustering in protein structures
Atanas Kamburov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Mantle cell lymphoma: evolving management strategies
Elias Campo et al.
BLOOD (2015)
The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells
Jenny Zhang et al.
BLOOD (2014)
Pharmacological and genomic profiling identifies NF-kappa B-targeted treatment strategies for mantle cell lymphoma
Rami Rahal et al.
NATURE MEDICINE (2014)
MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens
Wei Li et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
CHOP and DHAP plus rituximab followed by autologous stem cell transplantation in mantle cell lymphoma: a phase 2 study from the Groupe d'Etude des Lymphomes de l'Adulte
Richard Delarue et al.
BLOOD (2013)
The E3 ubiquitin ligase UBR5 is recurrently mutated in mantle cell lymphoma
Barbara Meissner et al.
BLOOD (2013)
Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
Dan A. Landau et al.
CELL (2013)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Silvia Bea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma
Robert Kridel et al.
BLOOD (2012)
Molecular Subsets of Mantle Cell Lymphoma Defined by the IGHV Mutational Status and SOX11 Expression Have Distinct Biologic and Clinical Features
Alba Navarro et al.
CANCER RESEARCH (2012)
Molecular pathogenesis of mantle cell lymphoma
Pedro Jares et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Absolute quantification of somatic DNA alterations in human cancer
Scott L. Carter et al.
NATURE BIOTECHNOLOGY (2012)
High-Resolution Genomic Screening in Mantle Cell Lymphoma-Specific Changes Correlate with Genomic Complexity, the Proliferation Signature and Survival
Anna M. Halldorsdottir et al.
GENES CHROMOSOMES & CANCER (2011)
Impact of TP53 mutation and 17p deletion in mantle cell lymphoma
A. M. Halldorsdottir et al.
LEUKEMIA (2011)
A framework for variation discovery and genotyping using next-generation DNA sequencing data
Mark A. DePristo et al.
NATURE GENETICS (2011)
Is There a Role for Watch and Wait in Patients With Mantle Cell Lymphoma?
Peter Martin et al.
SEMINARS IN HEMATOLOGY (2011)
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling
Elena M. Hartmann et al.
BLOOD (2010)
Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma
Veronica Fernandez et al.
CANCER RESEARCH (2010)
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
Aaron McKenna et al.
GENOME RESEARCH (2010)
The Mantle Cell Lymphoma International Prognostic Index: Does it work in routine practice?
S. Y. Lim et al.
ONCOLOGY LETTERS (2010)
Fast and accurate short read alignment with Burrows-Wheeler transform
Heng Li et al.
BIOINFORMATICS (2009)
Uniparental disomies, homozygous deletions, amplifications, and target genes in mantle cell lymphoma revealed by integrative high-resolution whole-genome profiling
Silvia Bea et al.
BLOOD (2009)
Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
Annina Herrmann et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma
Peter Martin et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
t(11;14)-positive clones can persist over a long period of time in the peripheral blood of healthy individuals
Y. Lecluse et al.
LEUKEMIA (2009)
A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma
Eva Hoster et al.
BLOOD (2008)
Ki-67 predicts outcome in advanced-stage mantle cell lymphoma patients treated with anti-CD20 immunochemotherapy: results from randomized trials of the European MCL Network and the German Low Grade lymphoma Study Group
Olaf Determann et al.
BLOOD (2008)
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature
Itziar Salaverria et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome
F Rubio-Moscardo et al.
BLOOD (2005)
Metagenes and molecular pattern discovery using matrix factorization
JP Brunet et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald et al.
CANCER CELL (2003)
分享论文
